219 related articles for article (PubMed ID: 11999623)
1. Visual field constriction and electrophysiological changes associated with vigabatrin.
Besch D; Kurtenbach A; Apfelstedt-Sylla E; Sadowski B; Dennig D; Asenbauer C; Zrenner E; Schiefer U
Doc Ophthalmol; 2002 Mar; 104(2):151-70. PubMed ID: 11999623
[TBL] [Abstract][Full Text] [Related]
2. The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms.
Comaish IF; Gorman C; Brimlow GM; Barber C; Orr GM; Galloway NR
Doc Ophthalmol; 2002 Mar; 104(2):195-212. PubMed ID: 11999627
[TBL] [Abstract][Full Text] [Related]
3. Visual field and electrophysiological abnormalities due to vigabatrin.
van der Torren K; Graniewski-Wijnands HS; Polak BC
Doc Ophthalmol; 2002 Mar; 104(2):181-8. PubMed ID: 11999625
[TBL] [Abstract][Full Text] [Related]
4. Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction.
Harding GF; Wild JM; Robertson KA; Lawden MC; Betts TA; Barber C; Barnes PM
Epilepsia; 2000 Nov; 41(11):1420-31. PubMed ID: 11077455
[TBL] [Abstract][Full Text] [Related]
5. Vigabatrin and retinal changes.
Jensen H; Sjö O; Uldall P; Gram L
Doc Ophthalmol; 2002 Mar; 104(2):171-80. PubMed ID: 11999624
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of the retinal nerve fibre layer and reduced retinal function assessed by optical coherence tomography and full-field electroretinography in patients exposed to vigabatrin medication.
Kjellström U; Andréasson S; Ponjavic V
Acta Ophthalmol; 2014 Mar; 92(2):149-57. PubMed ID: 23387307
[TBL] [Abstract][Full Text] [Related]
7. Full-field ERG and visual fields in patients 5 years after discontinuing vigabatrin therapy.
Kjellström U; Lövestam-Adrian M; Andréasson S; Ponjavic V
Doc Ophthalmol; 2008 Sep; 117(2):93-101. PubMed ID: 18188629
[TBL] [Abstract][Full Text] [Related]
8. Electro-ophthalmological recovery after withdrawal from vigabatrin.
Graniewski-Wijnands HS; van der Torren K
Doc Ophthalmol; 2002 Mar; 104(2):189-94. PubMed ID: 11999626
[TBL] [Abstract][Full Text] [Related]
9. Visual field defects associated with vigabatrin therapy.
Lawden MC; Eke T; Degg C; Harding GF; Wild JM
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):716-22. PubMed ID: 10567485
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin effect on inner retinal function.
Coupland SG; Zackon DH; Leonard BC; Ross TM
Ophthalmology; 2001 Aug; 108(8):1493-6; discussion 1497-8. PubMed ID: 11470707
[TBL] [Abstract][Full Text] [Related]
11. Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication.
Ponjavic V; Andréasson S
Doc Ophthalmol; 2001 Jan; 102(1):63-72. PubMed ID: 11475366
[TBL] [Abstract][Full Text] [Related]
12. Binasal visual field defects are not specific to vigabatrin.
Gonzalez P; Sills GJ; Parks S; Kelly K; Stephen LJ; Keating D; Dutton GN; Brodie MJ
Epilepsy Behav; 2009 Nov; 16(3):521-6. PubMed ID: 19815465
[TBL] [Abstract][Full Text] [Related]
13. [Retinal dysfunction in patients treated with vigabatrin].
Podboraczyńska-Jodkoi K; Lubiński W; Hampel-Osipowicz E
Klin Oczna; 2007; 109(1-3):85-8. PubMed ID: 17687922
[TBL] [Abstract][Full Text] [Related]
14. Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss.
Harding GF; Wild JM; Robertson KA; Rietbrock S; Martinez C
Neurology; 2000 Aug; 55(3):347-52. PubMed ID: 10932265
[TBL] [Abstract][Full Text] [Related]
15. Visual function loss from vigabatrin: effect of stopping the drug.
Johnson MA; Krauss GL; Miller NR; Medura M; Paul SR
Neurology; 2000 Jul; 55(1):40-5. PubMed ID: 10891902
[TBL] [Abstract][Full Text] [Related]
16. Changes in the ERG d-wave with vigabatrin treatment in a pediatric cohort.
Dragas R; Westall C; Wright T
Doc Ophthalmol; 2014 Oct; 129(2):97-104. PubMed ID: 25008578
[TBL] [Abstract][Full Text] [Related]
17. Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated children.
Harding GF; Spencer EL; Wild JM; Conway M; Bohn RL
Neurology; 2002 Apr; 58(8):1261-5. PubMed ID: 11971096
[TBL] [Abstract][Full Text] [Related]
18. The value of electrophysiology results in patients with epilepsy and vigabatrin associated visual field loss.
Hardus P; Verduin WM; Berendschot TT; Kamermans M; Postma G; Stilma JS; van Veelen CW
Acta Ophthalmol Scand; 2001 Apr; 79(2):169-74. PubMed ID: 11284756
[TBL] [Abstract][Full Text] [Related]
19. [Electrophysiological monitoring of epileptic patients treated with Vigabatrin].
Rigolet MH; Baulac M; Nordmann JP
J Fr Ophtalmol; 2005 Jun; 28(6):635-41. PubMed ID: 16141930
[TBL] [Abstract][Full Text] [Related]
20. Symptomatic and asymptomatic visual loss in patients taking vigabatrin.
Daneshvar H; Racette L; Coupland SG; Kertes PJ; Guberman A; Zackon D
Ophthalmology; 1999 Sep; 106(9):1792-8. PubMed ID: 10485552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
